- List
- By Topic
- On Map
- Search Details

"Subcutaneous panniculitis-like T-cell lymphoma"
Need help? See RSS Feeds
Choose a feed type:

"Subcutaneous panniculitis-like T-cell lymphoma" (8 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01445535 | Active, not recruiting | Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas |
|
|
Interventional | Phase 1 |
|
NIH |
|
|
15 | All | 18 Years to 120 Years (Adult, Senior) | NCT01445535 | 090065 09-C-0065 |
January 13, 2009 | April 1, 2011 | October 1, 2019 | October 3, 2011 | March 6, 2018 |
|
||
2 | NCT02533700 | Unknown † | CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL |
|
|
Interventional | Phase 4 |
|
Other |
|
|
1 | All | 16 Years to 70 Years (Child, Adult, Senior) | NCT02533700 | WXin | September 2015 | September 2017 | December 2017 | August 27, 2015 | April 19, 2016 |
|
||
3 | NCT01746992 | Active, not recruiting | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma |
|
|
Interventional | Phase 4 |
|
Other |
|
|
200 | All | 18 Years to 65 Years (Adult) | NCT01746992 | CTOP | September 2012 | September 2018 | December 2018 | December 11, 2012 | November 14, 2017 |
|
||
4 | NCT02652715 | Recruiting | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02652715 | LS1581 NCI-2015-02149 15-006720 P30CA015083 |
January 2016 | May 2021 | May 2021 | January 12, 2016 | February 6, 2018 |
|
||
5 | NCT01787409 | Recruiting | Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
713 | All | 18 Years and older (Adult, Senior) | NCT01787409 | LS1293 NCI-2013-00037 P30CA015083 |
March 2013 | September 2018 | September 2018 | February 8, 2013 | July 7, 2017 |
|
||
6 | NCT00671112 | Terminated | Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT00671112 | CASE2407 P30CA043703 CASE-2407 NCI-2010-01386 |
June 2008 | October 2015 | May 5, 2008 | October 28, 2015 |
|
|||
7 | NCT00810576 | Terminated Has Results |
Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
1 | All | 18 Years and older (Adult, Senior) | NCT00810576 | 2007-0658 | January 2009 | April 2010 | April 2010 | December 18, 2008 | August 7, 2012 | July 9, 2010 |
|
|
8 | NCT00787527 | Completed Has Results |
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / Industry |
|
|
14 | All | 18 Years and older (Adult, Senior) | NCT00787527 | 2008-0484 | November 2008 | December 2012 | December 2012 | November 7, 2008 | September 9, 2014 | September 9, 2014 |
|
† Study has passed its completion date and status has not been verified in more than two years.